Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed-Dose Study of Escitalopram in Combination With Two Fixed Doses of Gaboxadol Compared to Escitalopram in Major Depressive Disorder

NCT00807248 is registered in ClinicalTrials.gov with H. Lundbeck A/S as lead sponsor.

NCT NCT00807248
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00807248 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed-Dose Study of Escitalopram in Combination With Two Fixed Doses of Gaboxadol Compared to Escitalopram in Major Depressive Disorder
Lead sponsor
H. Lundbeck A/S
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2008
Completion date
February 28, 2010
Enrollment
490 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder